Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

BCG

Baltic Classifieds Group

BTG plc is a life science technology company that develops and commercializes a range of pharmaceutical products, with a strong focus on neurological and vascular disorders. The company has a globa...

Baltic Classifieds Group Annual Report 2023

Healthcare Biotechnology LSE 1001-5000

ZNO

Zoono Group Limited

Zoono Group Limited is a New Zealand-based company that specializes in the research, development, and sale of antimicrobial products. The company offers a wide range of products, including hand san...

Zoono Group Limited Annual Report 2023

Biotechnology ASX 11-50

DARE

Daré Bioscience

San Diego-based clinical-stage biopharmaceutical company Daré Bioscience, Inc. is committed to promoting women's health in the United States by identifying, developing, and marketing products. The ...

Daré Bioscience Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

RNN

Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals is a biopharmaceutical company that is primarily focused on developing treatments for cancer and disorders of the central nervous system. The company is in the early stages o...

Rexahn Pharmaceuticals, Inc. Annual Report 2018

Healthcare Biotechnology AMEX 11-50

ADRO

Aduro BioTech Inc

Aduro BioTech is a clinical-stage company that focuses on developing technology platforms to stimulate immune responses against cancer. The company's lead product candidate, CRS-207, is currently i...

Aduro BioTech Inc Annual Report 2018

Healthcare Biotechnology NASDAQ 51-200

BCTX

BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp., a biotechnology company focused on immuno-oncology, is making strides in the development of new cancer therapies. With their lead drug candidate, Bria-IMT, currently in...

BriaCell Therapeutics Corp. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

CRNX

Crinetics Pharmaceuticals

Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company dedicated to tackling endocrine diseases and endocrine-related tumors. Their primary product candidate, Paltusotine, is an...

Crinetics Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

PBYI

Puma Biotechnology

Puma Biotechnology Aims to Revolutionize Cancer Care with Innovative Drug Candidates Los Angeles-based Puma Biotechnology, Inc., a biopharmaceutical company, is dedicated to developing and commerc...

Puma Biotechnology Annual Report 2023

Healthcare Biotechnology NYSE 51-200

XTNT

Xtant Medical Holdings

Xtant Medical Holdings, Inc., a regenerative medicine products and medical devices manufacturer, operates in the United States and international markets for neurological and orthopedic surgery. The...

Xtant Medical Holdings Annual Report 2023

Healthcare Biotechnology NYSE 201-500

ISEE

IVERIC bio

Iveric Bio is a biopharmaceutical company that specializes in the development of innovative treatment options for diseases affecting the retina. Their focus is on age-related retinal diseases and i...

IVERIC bio Annual Report 2021

Healthcare Biotechnology NASDAQ 11-50

UROV

Urovant Sciences Ltd.

Urovant Sciences, a clinical-stage biopharmaceutical company, is focused on developing and commercializing innovative therapies for urologic conditions. Their lead product candidate, vibegron, is a...

Urovant Sciences Ltd. Annual Report 2019

Healthcare Biotechnology NASDAQ 51-200

BIVI

BioVie Inc.

BioVie Inc., a clinical stage biopharmaceutical firm headquartered in Carson City, Nevada, is making strides in the discovery, development, and commercialization of drugs geared towards the treatme...

BioVie Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

VKTX

Viking Therapeutics

Viking Therapeutics Inc., a biopharmaceutical company in its clinical-stage, is committed to developing innovative therapies for metabolic and endocrine disorders. The company's premier drug candid...

Viking Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

SPRO

Spero Therapeutics

Cambridge-based clinical-stage biopharmaceutical company Spero Therapeutics, Inc. is focusing its efforts on the challenging area of multi-drug resistant bacterial infections and rare diseases. The...

Spero Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

SRRK

Scholar Rock

Cambridge, Massachusetts-based biopharmaceutical company, Scholar Rock Holding Corporation, is devoted to pioneering medicines for the treatment of severe diseases where the activation of protein g...

Scholar Rock Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200